10 Stocks With Monster Gains Amid Market Turmoil

Page 3 of 3

4. Intellia Therapeutics Inc. (NASDAQ:NTLA)

Intellia Therapeutics snapped a three-day losing streak on Friday, jumping 5.04 percent to finish at $10 apiece, as investor funds fled technology stocks to lower-risk assets to mitigate risks from ongoing AI concerns.

Week-on-week, the stock grew 3 percent.

The rally can be supported by portfolio positioning on optimism for Lonvo-z’s approval by the Food and Drug Administration for the treatment of hereditary angioedema, with Intellia Therapeutics Inc. (NASDAQ:NTLA) noting that the agency has so far not requested unusual information regarding the therapy candidate.

The FDA set a deadline of March 10, 2027, for its decision on the listed firm’s biologics license application.

Additionally, it said that the FDA advised that it is not currently planning to hold an advisory committee to discuss the application.

If approved, Lonvo-z would become the world’s first in vivo CRISPR-based therapy and the only one-time treatment for HAE.

Lonvo-z aside, Intellia Therapeutics Inc. reported a 25.8 percent higher net loss of $127.48 million in the third quarter of the year, versus $101 million in the same period last year. It has yet to earn any revenue.

Total operating expenses increased by 3.4 percent to $129.49 million from $125.2 million year-on-year.

3. Medical Properties Trust Inc. (NYSE:MPT)

Medical Properties extended gains for a fourth consecutive day on Friday, surging 6.71 percent to close at $1.75 apiece, as investors fled technology stocks to other industries to mitigate risks from lingering AI concerns.

The stock mimicked the 16.64 percent rally in the healthcare sector, as investors poured funds into less risky assets amid the bloodbath in technology stocks. Week-on-week, its shares were up by 4.8 percent.

The rally can be supported by its strong earnings performance during the third quarter of the year, having swung to a net income attributable to shareholders of $201.58 million from a $77.73 million net loss attributable to stockholders in the same period last year.

Total revenues grew by 5.3 percent to $250 million from $237.5 million year-on-year.

“Our results this quarter demonstrate the decisive steps we have taken to strengthen our balance sheet and create greater flexibility to further reduce debt and pursue selective growth opportunities. As healthcare providers around the world seek new solutions to capital challenges, our business model is more important than ever, and we are well positioned to create long-term value for our shareholders,” Medical Properties Trust Inc. (NYSE:MPT) Chairman, President, and CEO Edward Aldag Jr. said.

Medical Properties Trust Inc. holds total assets of approximately $14.4 billion, including $8.3 billion of general acute facilities, $2.4 billion of behavioral health facilities and $1.6 billion of post-acute facilities.

2. Global Payments Inc. (NYSE:GPN)

Global Payments soared by 9.95 percent on Friday to end at $91.83 apiece, as investor sentiment was bolstered by news that its largest shareholder, GTCR, is weighing a full takeover of the company for $50 billion.

In a regulatory filing, GTCR said that it is working with other private equity firms to finance a possible deal, albeit no financial decision has been made.

The move followed the abandonment of a joint bid by GTCR and Clayton, Dubilier & Rice.

Earlier this week, a report by Reuters citing people privy to the matter said that the two investment firms halted talks given the complexities of the deal, although it noted that a revival remained possible at a later date or if another buyer emerges.

CD&R and GTCR planned to acquire Global Payments Inc. for $40 billion, a year after the latter agreed to a $22.7 billion deal to acquire another payments giant, Worldpay, from GTRC and FIS while disposing of its Issuer Solutions business to FIS for $13.5 billion.

Earlier this month, Global Payments Inc. reported a 56 percent decline in its net income in the third quarter of the year to $280.9 million from $635.2 million in the same period last year. Revenues increased by 63 percent to $3.3 billion from $2.02 billion.

Week-on-week, shares of the company finished flat.

1. The Gap Inc. (NYSE:GAP)

The Gap Inc. saw its share price jump by 11.44 percent on Friday to finish at $20.94 apiece, after reporting a strong earnings performance in the third quarter of the year, signaling that consumer spending remained strong despite the impact of tariffs and stubbornly high inflation.

In an updated report, the clothing retailer said that it was able to grow its net income for the period by 32 percent to $311 million from $236 million in the same period last year. Net sales inched up by 1.7 percent to $4.011 billion from $3.942 billion year-on-year.

Among all brands, only Gap and Old Navy registered growth, up 11 percent to $1.1 billion and 1 percent to $2.3 billion, respectively. Banana Republic and Athleta both fell 3 percent and 14 percent year-on-year.

Comparable sales ended flat, while store sales increased 1 percent year-on-year. Online sales grew 3 percent and represented 40 percent of total net sales.

Earnings aside, The Gap Inc. named Ashley Kechter as Brand President and Chief Executive Officer of Athleta, effective December 14, marking a return to the company where she began her career and spent 8 years serving in several leadership roles across brands.

Kechter brings more than two decades of experience leading and scaling multi-billion-dollar brands across apparel, activewear and lifestyle.

She is expected to join the company from Vuori, where she serves as global president. She also served as global brand president for Fabletics.  Week-on-week, shares of the company finished flat.

READ NEXT: 10 Best US Stocks to Buy Under $25 and Bruce Berkowitz’s 10 Biggest Stock Bets for 2027

Follow Insider Monkey on Google News.

Page 3 of 3